We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesLongevity Health Holdings, Inc.

Longevity Health Holdings, Inc.

Consumer Defensive Household & Personal Products
PortfolioPortfolio WatchlistWatchlist
Company price
0.125 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
9
Market Cap
0.42M

Momentum Score

…

Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.12
Low
0.12
High
52 Week Price Range
0.17
Low
1.08
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Longevity Health Holdings, Inc. is a Nasdaq-listed company with limited publicly available information about its operations; it is described as operating in healthcare for aging populations. Long-term growth drivers could include demographic aging and rising demand for senior care services, which may benefit a successfully scaled operator. Investors may find exposure to aging-population trends attractive but should require clearer operational and financial disclosure.
Principal risks are scant public disclosures, execution and financing uncertainty, and regulatory exposure inherent to healthcare services.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.12
Dividend Yield
-
Revenue TTM
1.69M
Revenue Per Share
0.85
Gross Profit TTM
0.72M
Debt / Equity
-0.09
ROE
-
Net Debt
-0.21M
ROCE
123.46%
Diluted EPS TTM
-3.26

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -6.87M -10.75M -16.21M -9.05M -0.33M
Net income -6.91M -10.37M -15.45M -9.05M -6.48M
Selling general administrative 5.91M 3.72M 2.62M 3.22M 0.86M
Selling and marketing expenses 1.42M 0.19M - - -
Gross profit 1.09M 0.04M -0.12M -0.24M -
Reconciled depreciation 0.22M 0.20M 0.12M 0.24M 0.24M
Ebit -6.85M -10.70M -15.32M -5.30M -0.33M
Ebitda -6.64M -10.50M -15.19M -5.06M -0.09M
Depreciation and amortization 0.22M 0.20M 0.12M 0.24M 0.24M
Operating income -7.11M -5.00M -5.22M -5.51M -0.47M
Other operating expenses 9.02M 5.05M 5.22M 5.51M 1.94M
Interest expense 0.02M 0.05M 0.89M 3.75M 2.50M
Tax provision 0.04M -0.10M 0.00M 0.00M 0.00M
Net interest income -0.02M -0.05M -0.89M -3.75M -2.50M
Income tax expense 0.04M -0.10M -0.76M 0.39M 2.54M
Total revenue 1.91M 0.05M 0.00M 0.00M 0.00M
Total operating expenses 8.20M 5.04M 5.09M 5.27M 1.94M
Cost of revenue 0.82M 0.01M 0.12M 0.24M -
Total other income expense net 0.24M -5.75M -10.99M -3.54M 0.14M
Net income from continuing ops -6.91M -10.65M -16.21M -9.05M -6.48M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2.37M 1.47M 63.95M 1.75M 1.56M
Intangible assets 0.02M 0.02M 0.02M 0.03M 0.03M
Other current assets 0.24M 0.38M 59.78M 0.48M -0.60M
Total liab 8.23M 6.19M 39.20M 39.54M 31.13M
Total stockholder equity -5.87M -4.71M 24.75M -37.79M -29.58M
Other current liab 3.00M 2.98M 32.65M 0.46M 3.84M
Common stock 0.00M 0.00M 0.00M 0.01M 0.04M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.04M
Retained earnings -75.78M -68.87M -58.50M -42.38M -32.77M
Cash 0.71M 0.16M 2.91M 0.13M 0.77M
Total current liabilities 7.92M 5.88M 38.50M 7.30M 15.80M
Current deferred revenue - - - 1.39M 2.37M
Net debt -0.21M 0.48M -0.78M 3.61M 8.91M
Short term debt 0.29M 0.33M 1.44M 2.91M 8.72M
Short long term debt 0.19M 0.24M 1.29M 2.78M 8.60M
Short long term debt total 0.50M 0.64M 2.14M 3.74M 9.69M
Other stockholder equity 69.91M 64.16M 83.25M 4.59M 3.16M
Total current assets 1.95M 0.96M 62.90M 0.61M 0.18M
Net receivables 0.04M 0.31M 0.20M - -
Long term debt - - - - 0.00M
Inventory 0.96M 0.11M 0.00M - -
Accounts payable 4.49M 4.06M 4.42M 2.14M 0.87M
Accumulated other comprehensive income - - - -31.42M -
Non currrent assets other - - - -156.69M -154.45M
Non current assets total 0.42M 0.52M 1.05M 1.14M 1.38M
Capital lease obligations 0.31M 0.40M 0.85M 0.96M 1.08M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.75M -0.03M -0.01M -0.01M
Total cashflows from investing activities -0.16M -0.75M -0.03M -0.01M -0.01M
Net borrowings -0.44M -0.22M -1.34M 2.75M 1.12M
Total cash from financing activities 4.04M 2.38M 11.16M 3.93M 1.20M
Net income -6.91M -11.80M -15.45M -9.05M -6.48M
Change in cash 0.55M -2.76M 2.78M 0.12M 0.01M
Begin period cash flow 0.16M 2.91M 0.13M 0.01M 0.00M
End period cash flow 0.71M 0.16M 2.91M 0.13M 0.01M
Total cash from operating activities -3.33M -4.39M -8.35M -3.81M -1.18M
Issuance of capital stock 3.48M 2.69M 0.00M 1.06M 0.00M
Depreciation 0.22M 0.20M 0.12M 0.24M 0.24M
Other cashflows from investing activities - - - - 154.44M
Change to inventory 0.37M -0.11M 0.20M - -
Change to account receivables 0.35M -0.10M -0.20M - -
Sale purchase of stock - - 0.00M -0.00M 0.00M
Other cashflows from financing activities - -0.09M 14.32M 1.19M 0.07M
Capital expenditures 0.01M 0.00M 0.03M 0.01M 0.01M
Change in working capital 2.76M 0.67M -3.42M 2.34M 0.95M
Stock based compensation 0.69M 0.83M 0.67M 0.64M 0.25M
Other non cash items -0.09M 5.72M 9.73M 2.22M 1.35M
Free cash flow -3.34M -4.39M -8.38M -3.44M -1.18M

Peer Comparison*

Sector: Consumer Defensive Industry: Household & Personal Products

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
XAGE
Longevity Health Holdings, Inc.		 -
-%		 0.12 - - 0.25 1.91 0.42
PG
Procter & Gamble Company		 1.27
0.76%		 168.94 23.58 22.62 4.07 7.24 4.40
LRLCF
L'Oréal S.A		 -
-%		 483.80 41.14 34.25 6.52 8.59 6.67
LRLCY
L’Oreal Co ADR		 -0.40
0.40%		 98.99 32.44 25.64 5.16 6.03 4.79
UL
Unilever PLC ADR		 0.08
0.12%		 65.86 21.53 16.39 2.66 7.29 2.77

Profile*

Longevity Health Holdings, Inc.

Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

2403 Sidney Street, Pittsburgh, PA, United States, 15203

919 313 9633

https://healthxage.com

10

Name Title Year Born
Mr. Bryan J. Cassaday Chief Financial Officer 1969
Mr. Janakiram Ajjarapu CEO & Chairman 1969
Dr. Phil Campbell Ph.D. Founder and Chief Scientific Officer NA
Dr. Lee Weiss Ph.D. Founder NA
Dr. James Burgess M.D. Founder NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…